Summary
- Avantor has filed to raise $100 million in an IPO, although the final amount may be much higher.
- The firm is the result of recent large mergers and provides a wide range of scientific products to various industry verticals worldwide.
- VNOR is debt-heavy and we can't determine how well the company is doing on an organic basis due to its recent large M&A activity.
- This idea was discussed in more depth with members of my private investing community, IPO Edge. Start your free trial today »
Quick Take
Avantor (VNOR) intends to raise gross proceeds of $100 million from a U.S. IPO, according to an S-1 registration statement.
The firm provides essential products and services for the life sciences and advanced technology industries.
VNOR is the result of recent large combinations, so we can’t tell whether it is growing organically. Also, the firm will use the IPO proceeds to pay off its private equity sponsor, rather than going toward its business plan.
